This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
Hillier, L.D., Lennon, G. et al. 1996. Genome Res. 6: 807–828.
Aaronson, J.S. et al. 1996. Genome Res. 6: 829–845.
Bassett, D.E. Jr. et al. 1997. Nat. Genet. 15: 339–344.
Brown, M.S. and Goldstein, J.L. 1986. Science 232: 34–47.
Brown, M.S. and Goldstein, J.L. 1996. Science 272: 629.
Fey, R. and Pearson, N. 1996. Lancet 347: 1389–1390.
Miklos, G.L. and Rubin, G.M. 1996. Cell 86: 521–529.
Hodgkin, J. et al. 1995. Science 270: 410–414.
Karim, F.D. et al. 1996. Genetics 143: 315–329.
Therrien, M. et al. 1995. Cell 83: 879–888.
Artavanis-Tsakonas, S. et al. 1995. Science 268: 225–232.
Christine, M. et al. 1997. Cell 90: 281–291.
Duojia, P. and Rubin, G.M. 1997. Cell 90: 271–280.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Scangos, G. Drug discovery in the postgenomic era. Nat Biotechnol 15, 1220–1221 (1997). https://doi.org/10.1038/nbt1197-1220
Issue date:
DOI: https://doi.org/10.1038/nbt1197-1220
This article is cited by
-
‘Genomics’: Buzzword or reality?
Journal of Biomedical Science (1999)
-
Why pharmacogenomics? Why now?
Nature Biotechnology (1998)
-
Why pharmacogenomics? Why now?
Nature Biotechnology (1998)